Dr. Alachkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N. Wolfe Street
Sheikh Zayed Tower Ross 971
Baltimore, MD 21287Phone+1 410-955-5045Fax+1 410-614-1643- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Nephrology, 2006 - 2009
- Wright State UniversityResidency, Internal Medicine, 2001 - 2004
- University of Aleppo Faculty of MedicineClass of 1994, MD
Certifications & Licensure
- MD State Medical License 2003 - 2024
- PA State Medical License 2020 - 2022
- OH State Medical License 2001 - 2005
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection Start of enrollment: 2020 May 07
Publications & Presentations
PubMed
- 5 citationsThe Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts.Candice Roufosse, Maarten Naesens, Mark Haas, Carmen Lefaucheur, Roslyn B Mannon, Marjan Afrouzian, Nada Alachkar, Olivier Aubert, Serena M Bagnasco, Ibrahim Batal, Ch...> ;American Journal of Transplantation. 2024 Mar 1
- 1 citationsEvaluation of the Modified Oxford Score in Recurrent IgA Nephropathy in North American Kidney Transplant Recipients: The Banff Recurrent Glomerulonephritis Working Gro...Nada Alachkar, Marco Delsante, Ross S Greenberg, Abbal Koirala, Tarek Alhamad, Basmah Abdalla, Manish Anand, Christopher Blosser, Umberto Maggiore, Serena M Bagnasco, ...> ;Transplantation. 2023 Sep 1
- Automating kidney transplant diagnostics.Nissrin Alachkar, Nada Alachkar> ;Nature Medicine. 2023 May 1
- Join now to see all
Journal Articles
- Abatacept in B7-1-positive proteinuric kidney diseaseAlachkar N, Carter-Monroe N, Reiser J, N Engl J Med
- Nontraditional Sites for Vascular Anastomoses to Enable Kidney Transplantation in Patients with Major Systemic Venous ThrombosesNada Alachkar, Bonnie E Lonze, Robert A Montgomery, Nabil N Dagher, Clinical Transplantation
- Abatacept in B7-1-positive proteinuric kidney diseaseAlachkar N, Carter-Monroe N, Reiser J, N Engl J Med., 3/27/2014
Other
- Focal segmental glomerulosclerosis in the transplanted kidneyAlachkar N, Kaplan AA, Kwoh CH, Brennan DC
http://www.uptodate.com/contents/focal-segmental-glomerulosclerosis-in-the-transplanted-kidney
UpToDate, Wolters Kluwer Health - 2013-03-18
Authored Content
- Abatacept in B7-1-positive proteinuric kidney diseaseMarch 2014
Press Mentions
- Angiotensin II Receptor 1 Antibodies Associate with Post-Transplant Focal Segmental Glomerulosclerosis and ProteinuriaJuly 2nd, 2020
- Ten-Year Outcome of Eculizumab in Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome– a Single Center ExperienceMay 20th, 2020
Professional Memberships
- Fellow
Other Languages
- Arabic
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/nada-alachkar
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: